sofosbuvir

Ligand id: 7368

Name: sofosbuvir

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 11
Hydrogen bond donors 3
Rotatable bonds 11
Topological polar surface area 162.54
Molecular weight 529.16
XLogP 1.86
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (FDA (2013), EMA (2014))
IUPAC Name
propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
International Nonproprietary Names
INN number INN
9665 sofosbuvir
Synonyms
GI-7977 | PSI 7977 | Sovaldi®
Database Links
CAS Registry No. 1190307-88-0 (source: Scifinder)
ChEMBL Ligand CHEMBL1259059
DrugBank Ligand DB08934
PubChem CID 45375808
Search Google for chemical match using the InChIKey TTZHDVOVKQGIBA-IQWMDFIBSA-N
Search Google for chemicals with the same backbone TTZHDVOVKQGIBA
Search PubMed clinical trials sofosbuvir
Search PubMed titles sofosbuvir
Search PubMed titles/abstracts sofosbuvir
Search UniChem for chemical match using the InChIKey TTZHDVOVKQGIBA-IQWMDFIBSA-N
Search UniChem for chemicals with the same backbone TTZHDVOVKQGIBA
Wikipedia Sofosbuvir
Comments
Sofosbuvir is a nucleotide analogue whose action inhibits hepatitis C virus (HCV) RNA polymerase. It is on the World Health Organization's List of Essential Medicines (link to 2015 list).